(1)
P. SANDEEP; K. ILANGO. A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR. Journal of Pharmaceutical Negative Results 2022, 217-225.